3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Gastrointestinal
1
Conditions
Stomach Ulcer
1
Stomach Neoplasms
1
Overweight
1
Obesity
1
Interventions
Exercise
4
Counseling
3
Nutrition Assessment
2
Naltrexone
2
Metformin
2
Exenatide
2
Diet
2
Cognitive Behavioral Therapy
2
Caloric Restriction
2
Bupropion
2
sultamicillin
1
licogliflozin
1
drospirenone and ethinyl estradiol combination
1
drospirenone
1
bupropion hydrochloride, naltrexone hydrochoride drug combination
1
Tobacco Use Cessation Devices
1
Surveys and Questionnaires
1
Sugars
1
Sucrose
1
Standard of Care
1
Resistance Training
1
Psychology, Positive
1
Propofol
1
Motivational Interviewing
1
Mindfulness-Based Stress Reduction
1
Methods
1
Flutamide
1
Ethinyl Estradiol
1
Diet, Mediterranean
1
Diet Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Overweight
×
(2-(1R)-1-cyclopropyl)ethyl-6-isopropyl-phenol
×
Clear all
NCT05518929
2024-06-07
SpO2
RenJi Hospital
Phase 4
Completed
1,090 enrolled